4.6 Article

Role of Brain Liver X Receptor in Parkinson's Disease: Hidden Treasure and Emerging Opportunities

Journal

MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s12035-023-03561-y

Keywords

Parkinson's disease; Liver X receptor; Neurodegenerative diseases

Categories

Ask authors/readers for more resources

This review explores the potential role of liver X receptor (LXR) in Parkinson's disease (PD) neuropathology. LXRs have neuroprotective effects in different neurodegenerative diseases through regulating cholesterol metabolism and anti-inflammatory effects. By inhibiting the expression of inflammatory signaling pathways, LXRs can alleviate neuroinflammation, oxidative stress, mitochondrial dysfunction, and enhance BDNF signaling in PD.
Parkinson's disease (PD) is a neurodegenerative disease due to the degeneration of dopaminergic neurons (DNs) in the substantia nigra (SN). The liver X receptor (LXR) is involved in different neurodegenerative diseases. Therefore, the objective of the present review was to clarify the possible role of LXR in PD neuropathology. LXRs are the most common nuclear receptors of transcription factors that regulate cholesterol metabolism and have pleiotropic effects, including anti-inflammatory effects and reducing intracellular cholesterol accumulation. LXRs are highly expressed in the adult brain and act as endogenous sensors for intracellular cholesterol. LXRs have neuroprotective effects against the development of neuroinflammation in different neurodegenerative diseases by inhibiting the expression of pro-inflammatory cytokines. LXRs play an essential role in mitigating PD neuropathology by reducing the expression of inflammatory signaling pathways, neuroinflammation, oxidative stress, mitochondrial dysfunction, and enhancement of BDNF signaling.In conclusion, LXRs, through regulating brain cholesterol homeostasis, may be effectual in PD. Also, inhibition of node-like receptor pyrin 3 (NLRP3) inflammasome and nuclear factor kappa B (NF-& kappa;B) by LXRs could effectively prevent neuroinflammation in PD. Taken together, LXRs play a crucial role in PD neuropathology by inhibiting neuroinflammation and associated degeneration of DNs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Surgery

Is it about time to develop social surgery?

Christos Tsagkaris, Marios Papadakis, Lolita Matiashova

AMERICAN JOURNAL OF SURGERY (2023)

Review Pharmacology & Pharmacy

The phytochemical profiling, pharmacological activities, and safety of malva sylvestris: a review

Gaber El-Saber Batiha, Stephano Tambo Tene, John Oluwafemi Teibo, Hazem M. Shaheen, Oyerinde Samson Oluwatoba, Titilade Kehinde Ayandeyi Teibo, Hayder M. Al-kuraishy, Ali Al-Garbee, Athanasios Alexiou, Marios Papadakis

Summary: This review provides an overview of the traditional uses, phytochemistry, pharmacological activities, and safety of Malva sylvestris. The study found that the leaves and flowers of Malva sylvestris contain various bioactive compounds, which contribute to its anti-inflammatory, antimicrobial, hepatoprotective, laxative, antiproliferative, and antioxidant properties.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

Bioactive compounds, pharmacological actions and pharmacokinetics of Cupressus sempervirens

Gaber El-Saber Batiha, John Oluwafemi Teibo, Hazem M. Shaheen, Opeyemi Abigail Akinfe, Aya Ahmed Awad, Titilade Kehinde Ayandeyi Teibo, Athanasios Alexiou, Marios Papadakis

Summary: The roles of plants and their products in medicine cannot be underestimated. Cupressus sempervirens, a plant found in different regions, has been investigated for its biological properties and phytochemical composition. This review focuses on the interactions, traditional uses, and biological actions of Cupressus sempervirens and its products.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

A Potential Link Between Visceral Obesity and Risk of Alzheimer's Disease

Hayder M. Al-Kuraishy, Ali Al-Gareeb, Abdulrahman A. Alsayegh, Zaki H. Hakami, Nizar A. Khamjan, Hebatallah M. Saad, Gaber El-Saber Batiha, Michel De Waard

Summary: In this review, the potential link between visceral obesity (VO) and Alzheimer's disease (AD) is evaluated. Tissue hypoxia and inflammatory changes induced by VO may increase the risk of AD, and the abnormal insulin signaling pathway is also related to the pathogenesis of AD. Additionally, the enlargement of visceral adipose tissue is associated with the deposition of A beta, and the activation of various inflammatory signaling pathways has a negative impact on cognitive function and the progression of AD.

NEUROCHEMICAL RESEARCH (2023)

Article Cell Biology

Diacerein modulates TLR4/ NF-κB/IL-1β and TRPC1/CHOP signalling pathways in gentamicin-induced parotid toxicity in rats

Dalia Mohamed Ali, Mohamed H. Mahmoud, Rehab Ahmed Rifaai, Michael Atef Fawzy, Medhat Atta, Nermeen N. Welson, Gaber El-Saber Batiha, Athanasios Alexiou, Marios Papadakis, Walaa Yehia Abdelzaher

Summary: The aim of this study was to investigate the potential protective effect of diacerein (DIA) on gentamicin (GNT)-induced parotid toxicity in rats. The results showed that GNT caused oxidative stress, inflammation, apoptosis, and damage to the parotid gland, while DIA significantly alleviated these effects and improved the histopathological picture. It was also found that DIA modulated the TLR4/NF-kappa B/IL-1 beta and TRPC1/CHOP signaling pathways in the protection against GNT-induced parotid toxicity.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Review Pharmacology & Pharmacy

Morus alba: a comprehensive phytochemical and pharmacological review

Gaber El-Saber Batiha, Ali Esmail Al-Snafi, Mahdi M. M. Thuwaini, John Oluwafemi Teibo, Hazem M. M. Shaheen, Ayomide Peter Akomolafe, Titilade Kehinde Ayandeyi Teibo, Hayder M. M. Al-kuraishy, Ali I. I. Al-Garbeeb, Athanasios Alexiou, Marios Papadakis

Summary: Morus alba, a fast-growing shrub or tree, has various medicinal uses. The plant parts have been used to treat nerve disorders, as analgesics, antibacterials, and many more. The plant contains a wide range of chemical components and has shown various pharmacological effects, including antimicrobial, anti-inflammatory, and antioxidant properties.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Immunology

A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects

Mohammed Alrouji, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha

Summary: Parkinson's disease (PD) is a degenerative disorder caused by the damage to certain neurons in the brain. The use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat musculoskeletal problems in PD patients can have both beneficial and harmful effects on the progression of the disease. NSAIDs can potentially prevent the development of PD by reducing neuroinflammation, but they may also inhibit neuroprotective mechanisms and worsen neuroinflammation. In conclusion, the effect of NSAIDs on PD neuropathology is still uncertain and further research is needed.

INFLAMMOPHARMACOLOGY (2023)

Review Clinical Neurology

The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective

Naif H. Ali, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Saud A. Alnaaim, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad, Gaber El-Saber Batiha

Summary: This review explores the potential role of tPA and neuroserpin in the pathogenesis of AD. Increased PAI-1 activity in AD contributes to the accumulation of Aβ. Neuroserpin plays a critical role in AD development by inhibiting the neuroprotective effects of tPA and reducing Aβ clearance.

ACTA NEUROLOGICA BELGICA (2023)

Review Clinical Neurology

The potential link between acromegaly and risk of acute ischemic stroke in patients with pituitary adenoma: a new perspective

Saud A. Alnaaim, Hayder M. Al-kuraishy, Mohammad Mitran Zailaie, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad, Gaber El-Saber Batiha

Summary: Acromegaly, caused by benign GH-secreting pituitary adenoma, is associated with the development of acute ischemic stroke (AIS) through the formation of cerebral vessel aneurysm, thrombosis, alteration of cerebral microcirculation, and acromegaly-induced cardio-metabolic disorders.

ACTA NEUROLOGICA BELGICA (2023)

Review Cell Biology

The beneficial role of autophagy in multiple sclerosis: Yes or No?

Hayder M. Al-kuraishy, Majid S. Jabir, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha, Daniel J. Klionsky

Summary: This study explores the protective and harmful effects of autophagy in the pathogenesis of multiple sclerosis (MS). Autophagy can prevent the progression of MS by reducing oxidative stress and inflammatory disorders, but over-activated autophagy can worsen the neuropathology of MS. Additionally, autophagy can modulate cell proliferation and affect demyelination and remyelination. Overall, autophagy plays a significant role in the pathogenesis of MS.

AUTOPHAGY (2023)

Article Medicine, Research & Experimental

Fenofibrate and Diosmetin in a rat model of testicular toxicity: New insight on their protective mechanism through PPAR-α/NRF-2/HO-1 signaling pathway

Moneerah J. Alqahtani, Walaa A. Negm, Hebatallah M. Saad, Esraa A. Salem, Ismail A. Hussein, Hanaa A. Ibrahim

Summary: The present study investigated the potential protective effect of Fenofibrate (Fen), Diosmetin (D), and their combination against testicular damage caused by cisplatin (Cis). The results showed that Fen and D could alleviate the harmful effects of Cis on the testes through upregulation of antioxidant activities and downregulation of lipid peroxidation, apoptosis, and inflammation. Additionally, the combination therapy Fen/D40 exhibited a more pronounced enhancement of these effects than either treatment alone.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Review Cell Biology

New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway

Saud A. Alnaaim, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naif H. Ali, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad, Gaber El-Saber Batiha

Summary: Epilepsy is a chronic neurological disease characterized by recurrent seizures. Despite the effectiveness of anti-epileptic agents (AEAs) in controlling epilepsy, a significant proportion of patients do not respond to conventional treatment. Therefore, adding FDA-approved drugs with anti-seizure activity, such as metformin, to the treatment regimen is a logical approach. This review aims to explore the mechanism of action of metformin in epilepsy.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Review Cell Biology

Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective

Naif H. Ali, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Saud A. Alnaaim, Athanasios Alexiou, Marios Papadakis, Asmaa A. Khalifa, Hebatallah M. Saad, Gaber El-Saber Batiha

Summary: Alzheimer's disease (AD) is a neurodegenerative disease characterized by the accumulation of phosphorylated tau proteins and amyloid beta (A beta) deposition. NEP inhibitors might have both beneficial and deleterious effects on AD neuropathology. Clinical studies have shown promising safety findings regarding the use of ARNI.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Review Pharmacology & Pharmacy

Does vitamin D protect or treat Parkinson's disease? A narrative review

Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Hend Mostafa Selim, Athanasios Alexiou, Marios Papadakis, Walaa A. Negm, Gaber El-Saber Batiha

Summary: Parkinson's disease (PD) is a neurodegenerative brain disease caused by the loss of dopaminergic neurons in the substantia nigra. Vitamin D (VD) plays a critical role in maintaining brain functions and can protect against PD by modulating dopaminergic neurons and reducing oxidative stress and neuroinflammation. However, the therapeutic effect of VD in well-established PD remains controversial.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears

Mubarak Alruwaili, Hayder M. M. Al-kuraishy, Athanasios Alexiou, Marios Papadakis, Barakat M. M. ALRashdi, Omnya Elhussieny, Hebatallah M. M. Saad, Gaber El-Saber Batiha

Summary: Multiple sclerosis is an autoimmune neurodegenerative disease caused by immune cells damaging the myelin sheath. Fibrinogen plays a crucial role in the pathogenesis of MS by triggering neuroinflammation. Inhibition of the fibrinogen cascade may reduce MS severity.

NEUROCHEMICAL RESEARCH (2023)

No Data Available